A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Cerus Corp stock. As of the latest transaction made, Ark Investment Management LLC holds 21,545,196 shares of CERS stock, worth $42.4 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
21,545,196
Previous 20,914,326 3.02%
Holding current value
$42.4 Million
Previous $45.2 Million 9.86%
% of portfolio
0.29%
Previous 0.27%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$1.66 - $2.42 $1.05 Million - $1.53 Million
630,870 Added 3.02%
21,545,196 $40.7 Million
Q4 2023

Jan 17, 2024

BUY
$1.25 - $2.35 $1.07 Million - $2 Million
852,420 Added 4.25%
20,914,326 $45.2 Million
Q3 2023

Oct 18, 2023

SELL
$1.5 - $3.07 $893,227 - $1.83 Million
-595,485 Reduced 2.88%
20,061,906 $32.5 Million
Q2 2023

Jul 10, 2023

SELL
$1.79 - $2.9 $2.58 Million - $4.18 Million
-1,442,728 Reduced 6.53%
20,657,391 $50.8 Million
Q1 2023

Apr 17, 2023

BUY
$2.65 - $3.81 $16.5 Million - $23.8 Million
6,236,735 Added 39.32%
22,100,119 $65.6 Million
Q4 2022

Jan 24, 2023

SELL
$3.38 - $4.22 $3.35 Million - $4.18 Million
-990,491 Reduced 5.88%
15,863,384 $0
Q3 2022

Oct 17, 2022

SELL
$3.43 - $5.83 $882,151 - $1.5 Million
-257,187 Reduced 1.5%
16,853,875 $60.7 Million
Q2 2022

Jul 11, 2022

BUY
$4.41 - $5.69 $3.96 Million - $5.11 Million
897,215 Added 5.53%
17,111,062 $84.7 Million
Q1 2022

Apr 19, 2022

BUY
$4.81 - $6.99 $2.19 Million - $3.19 Million
455,803 Added 2.89%
16,213,847 $89 Million
Q4 2021

Jan 28, 2022

SELL
$5.97 - $7.93 $7.93 Million - $10.5 Million
-1,327,700 Reduced 7.77%
15,758,044 $107 Million
Q3 2021

Nov 12, 2021

SELL
$4.79 - $6.68 $18.5 Million - $25.8 Million
-3,857,167 Reduced 18.42%
17,085,744 $104 Million
Q2 2021

Aug 05, 2021

SELL
$5.35 - $6.35 $24.6 Million - $29.2 Million
-4,599,044 Reduced 18.01%
20,942,911 $124 Million
Q1 2021

May 13, 2021

SELL
$5.68 - $7.87 $22.9 Million - $31.7 Million
-4,030,310 Reduced 13.63%
25,541,955 $154 Million
Q4 2020

Feb 12, 2021

SELL
$5.25 - $8.56 $2.25 Million - $3.66 Million
-427,806 Reduced 1.43%
29,572,265 $205 Million
Q3 2020

Oct 30, 2020

BUY
$5.78 - $7.47 $47.6 Million - $61.6 Million
8,241,636 Added 37.88%
30,000,071 $188 Million
Q2 2020

Aug 11, 2020

BUY
$4.5 - $7.02 $34.9 Million - $54.4 Million
7,753,379 Added 55.36%
21,758,435 $144 Million
Q1 2020

May 14, 2020

BUY
$2.87 - $5.49 $13.2 Million - $25.2 Million
4,588,596 Added 48.73%
14,005,056 $65.1 Million
Q4 2019

Jan 31, 2020

BUY
$3.84 - $4.86 $2.82 Million - $3.56 Million
733,290 Added 8.44%
9,416,460 $39.7 Million
Q3 2019

Nov 12, 2019

BUY
$4.86 - $6.05 $924,119 - $1.15 Million
190,148 Added 2.24%
8,683,170 $44.8 Million
Q2 2019

Jul 30, 2019

BUY
$4.51 - $6.6 $3.85 Million - $5.63 Million
853,589 Added 11.17%
8,493,022 $47.7 Million
Q1 2019

May 13, 2019

BUY
$5.16 - $6.85 $4.64 Million - $6.16 Million
898,651 Added 13.33%
7,639,433 $47.6 Million
Q4 2018

Feb 01, 2019

BUY
$4.89 - $7.16 $1.18 Million - $1.73 Million
241,750 Added 3.72%
6,740,782 $34.2 Million
Q3 2018

Nov 07, 2018

BUY
$6.89 - $7.78 $5.54 Million - $6.25 Million
803,661 Added 14.11%
6,499,032 $46.9 Million
Q2 2018

Aug 07, 2018

BUY
$5.19 - $7.25 $2.3 Million - $3.21 Million
443,387 Added 8.44%
5,695,371 $38 Million
Q1 2018

May 14, 2018

BUY
$3.56 - $5.74 $6.01 Million - $9.69 Million
1,687,611 Added 47.35%
5,251,984 $28.8 Million
Q4 2017

Feb 12, 2018

BUY
$2.76 - $3.95 $2.43 Million - $3.48 Million
881,171 Added 32.84%
3,564,373 $12 Million
Q3 2017

Nov 09, 2017

BUY
$2.22 - $2.73 $2.23 Million - $2.74 Million
1,002,277 Added 59.63%
2,683,202 $7.33 Million
Q2 2017

Aug 11, 2017

BUY
N/A
938,647 Added 126.45%
1,680,925 $4.22 Million
Q1 2017

May 15, 2017

BUY
N/A
80,463 Added 12.16%
742,278 $3.3 Million
Q4 2016

Feb 13, 2017

BUY
N/A
661,815
661,815 $2.88 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $349M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.